New drug classes for the treatment of partial onset epilepsy: focus on perampanel
Jerry J Shih,1 William O Tatum,1 Leslie A Rudzinski21Department of Neurology, Mayo Clinic, Jacksonville, FL, USA; 2Department of Neurology, Emory University, Atlanta, GA, USAAbstract: Perampanel (2-[2-oxo-1-phenyl-5-pyridin-2-yl-1,2-dihydropyridin-3-yl] benzonitrile hydrate) is the latest in the lin...
Saved in:
Main Authors: | Shih JJ (Author), Tatum WO (Author), Rudzinski LA (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2013-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Perampanel: New drug for treatment of refractory partial onset seizures
by: Santosh Kumar Singh, et al.
Published: (2014) -
Perampanel: New drug for treatment of refractory partial onset seizures
by: Santosh Kumar Singh, et al.
Published: (2014) -
Pharmacoeconomic analysis of perampanel for resistance partial epilepsy
by: D. Yu. Belousov, et al.
Published: (2018) -
Value of Perampanel as Adjunctive Treatment for Partial-Onset Seizures in Epilepsy: Cost-Effectiveness and Budget Impact Analysis
by: Donger Zhang, et al.
Published: (2021) -
PERAMPANEL EFFECTIVENESS IN THE TREATMENT OF REFRACTERY PARTIAL ONSET EPILEPSY WITH OR WITHOUT SECONDARY GENERALIZATION: PHARMACOECONOMIC ANALYSIS FOR THE RUSSIAN FEDERATION HEALTH CARE SYSTEM
by: N. K. Mazina, et al.
Published: (2017)